ESMO Congress 2026

October 23–27, 2026 · Madrid · 176 items

← All topics

NATALEE

4 people · 4 posts

Heat trend for this story

Heat now 1·Peak in the comparable set 1 (Oct 23 05:00)·Change over 24h in the comparable set –·Participants now 2

Participants counted2

Heat over time

Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.

Floor

TodayOct 23Fri

Friday · 2 items

05:20
Daniel Ghinn@creationdanielScore6060
Right now there's growing anticipation among HCPs for @NovartisCancer NATALEE trial 6-year breast cancer survival results due to be presented at #ESMO26, according to @CREATION Int…
Same topic NATALEE · 4 peopleHeat 00 likes0 replies0 reposts
04:45
Timothée Olivier, MD@Timothee_MDScore6060
#ESMO26 tomorrow the 6-y survival results of the NATALEE trial will be presented in Madrid, 2:25 pm trial = 3 years adjuvant ribociclib in patients with HR+ HER2- early breast can…
Same topic NATALEE · 4 people ribociclib HER2Heat 00 likes0 replies0 reposts

Oct 22Thu

Thursday · 1 items

14:12
ozdogan_md@ozdogan_mdScore6060
Six years into NATALEE, the key question is no longer whether adjuvant ribociclib improves iDFS. Does the benefit remain durable-and is an OS signal emerging? LBA25 at #ESMO26, l…
Same topic NATALEE · 4 people LBA25 ribociclibHeat 11 like0 replies0 reposts

Oct 19Mon

Monday · 1 items

03:20
nicolobattisti@nicolobattistiScore6060
#ESMO26 breast cancer: my ten to watch OS from NATALEE, postMONARCH and FINER. CDK4 with FOURLIGHT-1. Pembro in HR+ with KEYNOTE-B49. T-DXd moves neoadjuvant in TALENT. ADC after …
Same topic NATALEE · 4 people POSTMONARCH FOURLIGHT-1 KEYNOTE-B49 #BREASTCANCERHeat 10 likes0 replies1 repost